Cargando…
Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod
Autores principales: | Abrahamowicz, Aleksandra A., Chow, Eric J., Child, Daniel D., Dao, Alexander, Morrison, Elizabeth D., Gill, Sharon K., Rogers, David M., Garvin, Kanishka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898960/ https://www.ncbi.nlm.nih.gov/pubmed/33602716 http://dx.doi.org/10.1212/NXI.0000000000000966 |
Ejemplares similares
-
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Barzegar, Mahdi, et al.
Publicado: (2020) -
Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod
por: de Jong, Brigit A., et al.
Publicado: (2018) -
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate
por: Ma, Brandy B., et al.
Publicado: (2016) -
HSV-2–related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS
por: Ikumi, Kazuhiro, et al.
Publicado: (2016) -
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
por: Palomares Cabeza, Virginia, et al.
Publicado: (2022)